We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+1.33%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9M
AUM Growth
-$920K
(-4%)
Cap. Flow
-$809M
Cap. Flow
% of AUM
-3,698.27%
Top 10 Holdings %
Top 10 Hldgs %
16.04%
Holding
3,383
New
122
Increased
1,094
Reduced
1,082
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$102M |
| 2 |
Cisco
CSCO
|
+$72.8M |
| 3 |
Cencora
COR
|
+$60.9M |
| 4 |
Merck
MRK
|
+$52.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$48.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$132M |
| 2 |
CBRE Group
CBRE
|
+$86M |
| 3 |
PPLI
People Inc
PPLI
|
+$72M |
| 4 |
Pfizer
PFE
|
+$67.2M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$54.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 12.47% |
| 4 | Industrials | 10.15% |
| 5 | Consumer Discretionary | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLGX
826
DELISTED
Corelogic, Inc.
CLGX
| $405 | ﹤0.01% |
8,759
| – | – |
|
827
Alliance Resource Partners
ARLP
$3.3B
| $402 | ﹤0.01% |
25,148
+6,000
| +31% | +$98K |
|
828
Pacira BioSciences
PCRX
$1.04B
| $401 | ﹤0.01% |
10,552
+8,760
| +489% | +$350K |
|
829
Invesco AI and Next Gen Software ETF
IGPT
$1.16B
| $400 | ﹤0.01% |
12,900
| – | – |
|
830
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.6B
| $400 | ﹤0.01% |
10,320
| – | – |
|
831
BWX Technologies
BWXT
$16.2B
| $399 | ﹤0.01% |
7,000
-621
| -8% | -$34.7K |
|
832
PRA Group
PRAA
$683M
| $397 | ﹤0.01% |
11,754
+173
| +1% | +$5.51K |
|
|
FRC
833
DELISTED
First Republic Bank
FRC
| $395 | ﹤0.01% |
4,085
-3,201
| -44% | -$304K |
|
834
Silicon Laboratories
SLAB
$7.17B
| $394 | ﹤0.01% |
3,543
-926
| -21% | -$100K |
|
835
ResMed
RMD
$29.5B
| $393 | ﹤0.01% |
2,913
-69
| -2% | -$9.04K |
|
|
MLPI
836
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $393 | ﹤0.01% |
+18,874
| New | +$404K |
|
837
J&J Snack Foods
JJSF
$1.46B
| $392 | ﹤0.01% |
2,044
-150
| -7% | -$27.2K |
|
838
Lamb Weston
LW
$7.3B
| $391 | ﹤0.01% |
5,390
-54,541
| -91% | -$3.74M |
|
839
FIVE9
FIVN
$1.96B
| $390 | ﹤0.01% |
7,263
+1,269
| +21% | +$71.4K |
|
840
Guardant Health
GH
$19.3B
| $387 | ﹤0.01% |
6,077
+5,542
| +1,036% | +$488K |
|
841
Emergent Biosolutions
EBS
$378M
| $386 | ﹤0.01% |
7,402
+56
| +0.8% | +$2.61K |
|
|
XYZ
842
Block Inc
XYZ
$48.4B
| $386 | ﹤0.01% |
6,245
+650
| +12% | +$44.2K |
|
843
BHP
BHP
$213B
| $384 | ﹤0.01% |
8,748
-159
| -2% | -$7.42K |
|
|
SF
844
Stifel
SF
$12.5B
| $382 | ﹤0.01% |
14,996
+5,276
| +54% | +$133K |
|
845
Golub Capital BDC
GBDC
$3.36B
| $380 | ﹤0.01% |
20,634
-4,413
| -18% | -$79.3K |
|
846
Brown-Forman Class A
BF.A
$12.8B
| $376 | ﹤0.01% |
6,298
| – | – |
|
847
Repligen
RGEN
$7.39B
| $375 | ﹤0.01% |
4,893
+3,008
| +160% | +$263K |
|
848
CAE Inc. Common Shares
CAE
$8.3B
| $370 | ﹤0.01% |
14,632
+80
| +0.5% | +$2.1K |
|
849
Sprott Physical Gold
PHYS
$14.7B
| $370 | ﹤0.01% |
31,380
| – | – |
|
850
iShares Global 100 ETF
IOO
$8.68B
| $366 | ﹤0.01% |
7,427
| – | – |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2019 Portfolio in Review
As of Q3 2019, Glenmede Trust held 3,383 positions worth $21.9M, down 4% from $22.8M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust withdrew a net $809M in Q3 2019, closing 180 positions and reducing 1,082 holdings. Its most notable exit was Callon Petroleum Company, an estimated $21.9K position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carlisle Companies worth $31K.
- Glenmede Trust's largest Q3 2019 buy was Carlisle Companies: 212,908 shares worth $31K.
- Glenmede Trust added most to American Tower in Q3 2019, an estimated $102M increase.
- Glenmede Trust's biggest Q3 2019 reduction was Boeing, cutting an estimated $132M.
- Glenmede Trust fully exited Callon Petroleum Company in Q3 2019, selling an estimated $21.9K.
- Glenmede Trust's ten largest holdings make up 16% of its $21.9M portfolio in Q3 2019.
- Glenmede Trust opened 122 new positions and closed 180 in Q3 2019.
- Glenmede Trust's portfolio value fell 4% quarter-over-quarter to $21.9M.
Based on Glenmede Trust's 13F filing for Q3 2019, filed 14 Nov 2019.